Company: DAWN
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026654
Chunk: 277

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 1B
Chunk 277
---
255754
     
    May 24, 2021

    4.2
     
    Amended and Restated Investors’ Rights Agreement, dated February 1, 2021, by and among Day One Biopharmaceuticals Holding Company, LLC and certain of its stockholders.
     
    S-1
     
    333-255754
     
    May 4, 2021

    4.3
     
    Form of Pre-Funded Warrant 
     
    8-K
     
    001-40431
     
    July 30, 2024

    4.4
     
    Form of Registration Rights Agreement
     
    8-K
     
    001-40431
     
    July 30, 2024

    4.5
     
    Description of Registrant’s Securities
     
    10-K
     
    001-40431 
     
    March 7, 2022 

    10.1^
     
    Form of Indemnification Agreement with directors and officers
     
    S-1
     
    333-255754
     
    May 4, 2021

    10.2^
     
    Form of Change in Control and Severance Agreement
     
    10-K
     
     001-40431
     
    March 7, 2022 

    10.3^
     
    2021 Equity Incentive Plan and forms of award agreements
     
    S-8
     
    333-276372
     
    January 4, 2024

128

    10.4^
     
    2021 Employee Stock Purchase Plan and forms of award agreements
     
    S-8
     
    333-276372
     
    January 4, 2024

    10.5^
     
    2022 Equity Inducement Plan and forms of agreement
     
    S-8
     
    333-268071
     
    October 31, 2022

    10.6†
     
    Office Lease, dated June 26, 2024, by and between Arcus Biosciences, Inc., a Delaware corporation, and Day One Biopharmaceuticals, Inc.

    X 

    10.7†
     
    Asset Transfer and License Agreement, effective as of December 16, 201